Deutsch Selected as Agency for Groundbreaking Medical Technology

Deutsch announced a partnership with Valeritas Holdings, Inc., a medical technology company, that it has been named their patient partner agency for their V-Go Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option that is worn like a patch, for patients with diabetes.

Deutsch will handle all creative, media, and data analytics for V-Go’s direct-to-consumer efforts. A fully integrated pilot patient campaign is being planned for roll out in multiple U.S. metropolitan markets in the first half of 2019.   

 

“Deutsch has a proven track record of telling brand stories that emotionally connect with consumers and elevate brands, so they’ll play a critical role in helping us develop a 360-marketing effort that will help empower millions of patients that currently struggle with insulin injections,” noted Valeritas’ President and CEO John Timberlake.  

“We’re excited to work with V-Go and the Valeritas team, an ambitious group that is patient centric and committed to making an impact,” said Tyler Swerdloff-Helms, EVP, and group account director. “They have a modern, unique and eloquent solution designed for patients with type 2 diabetes and a bold vision for the brand, and we can’t wait to help simplify lives for people with diabetes.” 

The CEO of Deutsch New York, Val DiFebo, said: “We can’t wait to get 2019 started. For new clients including Newman’s Own, Lactaid, Constant Contact and now V-Go, we’ll be showcasing a lineup of ambitious creative work designed to drive sales and deepen the brands’ engagement with consumers.”